Xi ZX - Search Results

Year	Number of Results
1984	1
1991	1
1993	2
1996	4
1997	2
1998	2
1999	1
2000	2
2002	6
2003	4
2004	4
2005	5
2006	3
2007	8
2008	7
2009	13
2010	8
2011	5
2012	7
2013	7
2014	4
2015	4
2016	8
2017	8
2018	11
2019	17
2020	15
2021	18
2022	13
2023	8
2024	6

1

β-caryophyllene inhibits heroin self-administration, but does not alter opioid-induced antinociception in rodents.

Galaj E, Bi GH, Xi ZX. Galaj E, et al. Among authors: xi zx. Neuropharmacology. 2024 Apr 16;252:109947. doi: 10.1016/j.neuropharm.2024.109947. Online ahead of print. Neuropharmacology. 2024. PMID: 38631564

2

AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects.

Soler-Cedeño O, Alton H, Bi GH, Linz E, Ji L, Makriyannis A, Xi ZX. Soler-Cedeño O, et al. Among authors: xi zx. Neuropsychopharmacology. 2024 Apr 10. doi: 10.1038/s41386-024-01861-y. Online ahead of print. Neuropsychopharmacology. 2024. PMID: 38600154

3

The selective D₃Receptor antagonist VK4-116 reverses loss of insight caused by self-administration of cocaine in rats.

Panayi MC, Shetty S, Porod M, Bahena L, Xi ZX, Newman AH, Schoenbaum G. Panayi MC, et al. Among authors: xi zx. Neuropsychopharmacology. 2024 Apr 6. doi: 10.1038/s41386-024-01858-7. Online ahead of print. Neuropsychopharmacology. 2024. PMID: 38582939

4

Optical Intracranial Self-Stimulation (oICSS): A New Behavioral Model for Studying Drug Reward and Aversion in Rodents.

Song R, Soler-Cedeño O, Xi ZX. Song R, et al. Among authors: xi zx. Int J Mol Sci. 2024 Mar 19;25(6):3455. doi: 10.3390/ijms25063455. Int J Mol Sci. 2024. PMID: 38542425 Free PMC article. Review.

5

GPR55 is expressed in glutamate neurons and functionally modulates drug taking and seeking in rats and mice.

He Y, Shen H, Bi GH, Zhang HY, Soler-Cedeño O, Alton H, Yang Y, Xi ZX. He Y, et al. Among authors: xi zx. Transl Psychiatry. 2024 Feb 19;14(1):101. doi: 10.1038/s41398-024-02820-3. Transl Psychiatry. 2024. PMID: 38374108 Free PMC article.

6

Modifications to 1-(4-(2-Bis(4-fluorophenyl)methyl)sulfinyl)alkyl Alicyclic Amines That Improve Metabolic Stability and Retain an Atypical DAT Inhibitor Profile.

Okorom AV, Camacho-Hernandez GA, Salomon K, Lee KH, Ku TC, Cao J, Won SJ, Friedman J, Lam J, Paule J, Rais R, Klein B, Xi ZX, Shi L, Loland CJ, Newman AH. Okorom AV, et al. Among authors: xi zx. J Med Chem. 2024 Jan 11;67(1):709-727. doi: 10.1021/acs.jmedchem.3c02037. Epub 2023 Dec 20. J Med Chem. 2024. PMID: 38117239

7

GPR55 is expressed in glutamate neurons and functionally modulates nicotine taking and seeking in rats and mice.

Xi ZX, He Y, Shen H, Bi GH, Zhang HY, Soler-Cedeno O, Alton H, Yang Y. Xi ZX, et al. Res Sq [Preprint]. 2023 Oct 3:rs.3.rs-3222344. doi: 10.21203/rs.3.rs-3222344/v1. Res Sq. 2023. PMID: 37886574 Free PMC article. Updated. Preprint.

8

PPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice.

Hempel B, Crissman M, Pari S, Klein B, Bi GH, Alton H, Xi ZX. Hempel B, et al. Among authors: xi zx. Mol Psychiatry. 2023 Oct;28(10):4203-4214. doi: 10.1038/s41380-023-02182-0. Epub 2023 Jul 21. Mol Psychiatry. 2023. PMID: 37479780 Free PMC article.

9

The selective D3-Receptor antagonist VK4-116 effectively treats behavioral inflexibility in rats caused by self-administration and withdrawal from cocaine.

Panayi MC, Shetty S, Porod M, Bahena L, Xi ZX, Newman AH, Schoenbaum G. Panayi MC, et al. Among authors: xi zx. bioRxiv [Preprint]. 2023 Sep 5:2023.09.03.556083. doi: 10.1101/2023.09.03.556083. bioRxiv. 2023. PMID: 37732238 Free PMC article. Preprint.

10

PPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice.

Xi ZX, Hempel B, Crissman M, Pari S, Klein B, Bi GH, Alton H. Xi ZX, et al. Res Sq [Preprint]. 2023 Mar 2:rs.3.rs-2614714. doi: 10.21203/rs.3.rs-2614714/v1. Res Sq. 2023. PMID: 36909477 Free PMC article. Updated. Preprint.

11

Dopamine D₃/D₂ Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders.

Gogarnoiu ES, Vogt CD, Sanchez J, Bonifazi A, Saab E, Shaik AB, Soler-Cedeño O, Bi GH, Klein B, Xi ZX, Lane JR, Newman AH. Gogarnoiu ES, et al. Among authors: xi zx. J Med Chem. 2023 Feb 9;66(3):1809-1834. doi: 10.1021/acs.jmedchem.2c01624. Epub 2023 Jan 20. J Med Chem. 2023. PMID: 36661568

12

Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in Mice.

Han X, Liang Y, Hempel B, Jordan CJ, Shen H, Bi GH, Li J, Xi ZX. Han X, et al. Among authors: xi zx. J Neurosci. 2023 Jan 18;43(3):373-385. doi: 10.1523/JNEUROSCI.1493-22.2022. Epub 2022 Dec 14. J Neurosci. 2023. PMID: 36517243 Free PMC article.

13

Current Perspectives on Selective Dopamine D₃ Receptor Antagonists/Partial Agonists as Pharmacotherapeutics for Opioid and Psychostimulant Use Disorders.

Newman AH, Xi ZX, Heidbreder C. Newman AH, et al. Among authors: xi zx. Curr Top Behav Neurosci. 2023;60:157-201. doi: 10.1007/7854_2022_347. Curr Top Behav Neurosci. 2023. PMID: 35543868 Free PMC article.

14

A highly D₃R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D₃R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder.

Galaj E, Bi GH, Klein B, Hempel B, Shaik AB, Gogarnoiu ES, Friedman J, Lam J, Rais R, Reed JF, Bloom SH, Swanson TL, Schmachtenberg JL, Eshleman AJ, Janowsky A, Xi ZX, Newman AH. Galaj E, et al. Among authors: xi zx. Neuropsychopharmacology. 2022 Dec;47(13):2309-2318. doi: 10.1038/s41386-022-01379-1. Epub 2022 Jul 25. Neuropsychopharmacology. 2022. PMID: 35879349 Free PMC article.

15

Pharmacological targeting of G protein-coupled receptor heteromers.

Moreno E, Casajuana-Martin N, Coyle M, Campos BC, Galaj E, Del Torrent CL, Seyedian A, Rea W, Cai NS, Bonifazi A, Florán B, Xi ZX, Guitart X, Casadó V, Newman AH, Bishop C, Pardo L, Ferré S. Moreno E, et al. Among authors: xi zx. Pharmacol Res. 2022 Nov;185:106476. doi: 10.1016/j.phrs.2022.106476. Epub 2022 Sep 28. Pharmacol Res. 2022. PMID: 36182040 Free PMC article.

16

Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge.

Soler-Cedeno O, Xi ZX. Soler-Cedeno O, et al. Among authors: xi zx. Cells. 2022 Oct 17;11(20):3262. doi: 10.3390/cells11203262. Cells. 2022. PMID: 36291128 Free PMC article. Review.

17

A red nucleus-VTA glutamate pathway underlies exercise reward and the therapeutic effect of exercise on cocaine use.

He Y, Madeo G, Liang Y, Zhang C, Hempel B, Liu X, Mu L, Liu S, Bi GH, Galaj E, Zhang HY, Shen H, McDevitt RA, Gardner EL, Liu QS, Xi ZX. He Y, et al. Among authors: xi zx. Sci Adv. 2022 Sep 2;8(35):eabo1440. doi: 10.1126/sciadv.abo1440. Epub 2022 Sep 2. Sci Adv. 2022. PMID: 36054363 Free PMC article.

18

Mitochondrial Clk1-iron-DAT regulation pathway: a possible new therapeutic target for methamphetamine use disorder.

Hempel B, Xi ZX. Hempel B, et al. Among authors: xi zx. Acta Pharmacol Sin. 2022 Aug;43(8):1887-1888. doi: 10.1038/s41401-021-00821-2. Epub 2021 Dec 6. Acta Pharmacol Sin. 2022. PMID: 34873315 Free PMC article. No abstract available.

19

Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research.

Galaj E, Hempel B, Moore A, Klein B, Bi GH, Gardner EL, Seltzman HH, Xi ZX. Galaj E, et al. Among authors: xi zx. Transl Psychiatry. 2022 Jul 18;12(1):286. doi: 10.1038/s41398-022-02059-w. Transl Psychiatry. 2022. PMID: 35851573 Free PMC article.

20

Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral β1 receptors.

You ZB, Galaj E, Alén F, Wang B, Bi GH, Moore AR, Buck T, Crissman M, Pari S, Xi ZX, Leggio L, Wise RA, Gardner EL. You ZB, et al. Among authors: xi zx. Neuropsychopharmacology. 2022 Jul;47(8):1449-1460. doi: 10.1038/s41386-021-01249-2. Epub 2021 Dec 18. Neuropsychopharmacology. 2022. PMID: 34923576 Free PMC article.

21

Involvement of the ghrelin system in the maintenance of oxycodone self-administration: converging evidence from endocrine, pharmacologic and transgenic approaches.

You ZB, Gardner EL, Galaj E, Moore AR, Buck T, Jordan CJ, Humburg BA, Bi GH, Xi ZX, Leggio L. You ZB, et al. Among authors: xi zx. Mol Psychiatry. 2022 Apr;27(4):2171-2181. doi: 10.1038/s41380-022-01438-5. Epub 2022 Jan 21. Mol Psychiatry. 2022. PMID: 35064236 Free PMC article.

22

Repeated cocaine administration upregulates CB₂ receptor expression in striatal medium-spiny neurons that express dopamine D₁ receptors in mice.

Zhang HY, De Biase L, Chandra R, Shen H, Liu QR, Gardner E, Lobo MK, Xi ZX. Zhang HY, et al. Among authors: xi zx. Acta Pharmacol Sin. 2022 Apr;43(4):876-888. doi: 10.1038/s41401-021-00712-6. Epub 2021 Jul 27. Acta Pharmacol Sin. 2022. PMID: 34316031 Free PMC article.

23

Elevation of Extracellular Glutamate by Blockade of Astrocyte Glutamate Transporters Inhibits Cocaine Reinforcement in Rats via a NMDA-GluN2B Receptor Mechanism.

Yang HJ, Hempel BJ, Bi GH, He Y, Zhang HY, Gardner EL, Xi ZX. Yang HJ, et al. Among authors: xi zx. J Neurosci. 2022 Mar 16;42(11):2327-2343. doi: 10.1523/JNEUROSCI.1432-21.2022. Epub 2022 Jan 28. J Neurosci. 2022. PMID: 35091501 Free PMC article.

24

Identification of the Risk Genes Associated With Vulnerability to Addiction: Major Findings From Transgenic Animals.

Jordan CJ, Xi ZX. Jordan CJ, et al. Among authors: xi zx. Front Neurosci. 2022 Jan 12;15:811192. doi: 10.3389/fnins.2021.811192. eCollection 2021. Front Neurosci. 2022. PMID: 35095405 Free PMC article. Review.

25

Receptor mechanisms underlying the CNS effects of cannabinoids: CB₁ receptor and beyond.

Hempel B, Xi ZX. Hempel B, et al. Among authors: xi zx. Adv Pharmacol. 2022;93:275-333. doi: 10.1016/bs.apha.2021.10.006. Epub 2021 Dec 13. Adv Pharmacol. 2022. PMID: 35341569 Free PMC article.

26

Synaptic Zn²⁺ potentiates the effects of cocaine on striatal dopamine neurotransmission and behavior.

Gomez JL, Bonaventura J, Keighron J, Wright KM, Marable DL, Rodriguez LA, Lam S, Carlton ML, Ellis RJ, Jordan CJ, Bi GH, Solis O, Pignatelli M, Bannon MJ, Xi ZX, Tanda G, Michaelides M. Gomez JL, et al. Among authors: xi zx. Transl Psychiatry. 2021 Nov 8;11(1):570. doi: 10.1038/s41398-021-01693-0. Transl Psychiatry. 2021. PMID: 34750356 Free PMC article.

27

Effects of the selective dopamine D₃ receptor antagonist PG01037 on morphine-induced hyperactivity and antinociception in mice.

Botz-Zapp CA, Foster SL, Pulley DM, Hempel B, Bi GH, Xi ZX, Newman AH, Weinshenker D, Manvich DF. Botz-Zapp CA, et al. Among authors: xi zx. Behav Brain Res. 2021 Oct 11;415:113506. doi: 10.1016/j.bbr.2021.113506. Epub 2021 Aug 2. Behav Brain Res. 2021. PMID: 34352292 Free PMC article.

28

β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms.

He XH, Galaj E, Bi GH, He Y, Hempel B, Wang YL, Gardner EL, Xi ZX. He XH, et al. Among authors: xi zx. Front Pharmacol. 2021 Sep 9;12:722476. doi: 10.3389/fphar.2021.722476. eCollection 2021. Front Pharmacol. 2021. PMID: 34566647 Free PMC article.

29

Pharmacology in the age of circuit neuroscience: Illuminating the neural mechanisms of reward, drug use and addiction and enlightening the future of translational research.

Jordan CJ, Wise R, Xi ZX. Jordan CJ, et al. Among authors: xi zx. Pharmacol Biochem Behav. 2021 Jul;206:173187. doi: 10.1016/j.pbb.2021.173187. Epub 2021 Apr 17. Pharmacol Biochem Behav. 2021. PMID: 33872665 Free PMC article. No abstract available.

30

Optogenetic brain-stimulation reward: A new procedure to re-evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter-Cre mice.

Humburg BA, Jordan CJ, Zhang HY, Shen H, Han X, Bi GH, Hempel B, Galaj E, Baumann MH, Xi ZX. Humburg BA, et al. Among authors: xi zx. Addict Biol. 2021 Jul;26(4):e13005. doi: 10.1111/adb.13005. Epub 2021 Feb 3. Addict Biol. 2021. PMID: 33538103 Free PMC article.

31

Cannabinoid CB₂ receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice.

Zhang HY, Shen H, Gao M, Ma Z, Hempel BJ, Bi GH, Gardner EL, Wu J, Xi ZX. Zhang HY, et al. Among authors: xi zx. Neuropharmacology. 2021 May 15;189:108538. doi: 10.1016/j.neuropharm.2021.108538. Epub 2021 Mar 28. Neuropharmacology. 2021. PMID: 33789118 Free PMC article.

32

Deletion of VGLUT2 in midbrain dopamine neurons attenuates dopamine and glutamate responses to methamphetamine in mice.

Shen H, Chen K, Marino RAM, McDevitt RA, Xi ZX. Shen H, et al. Among authors: xi zx. Pharmacol Biochem Behav. 2021 Mar;202:173104. doi: 10.1016/j.pbb.2021.173104. Epub 2021 Jan 12. Pharmacol Biochem Behav. 2021. PMID: 33444596 Free PMC article.

33

Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder.

Galaj E, Bi GH, Moore A, Chen K, He Y, Gardner E, Xi ZX. Galaj E, et al. Among authors: xi zx. Neuropsychopharmacology. 2021 Mar;46(4):860-870. doi: 10.1038/s41386-020-00885-4. Epub 2020 Oct 17. Neuropsychopharmacology. 2021. PMID: 33069159 Free PMC article.

34

Dissecting the role of CB₁ and CB₂ receptors in cannabinoid reward versus aversion using transgenic CB₁- and CB₂-knockout mice.

Li X, Hempel BJ, Yang HJ, Han X, Bi GH, Gardner EL, Xi ZX. Li X, et al. Among authors: xi zx. Eur Neuropsychopharmacol. 2021 Feb;43:38-51. doi: 10.1016/j.euroneuro.2020.11.019. Epub 2020 Dec 15. Eur Neuropsychopharmacol. 2021. PMID: 33334652 Free PMC article.

35

Modafinil and its structural analogs as atypical dopamine uptake inhibitors and potential medications for psychostimulant use disorder.

Tanda G, Hersey M, Hempel B, Xi ZX, Newman AH. Tanda G, et al. Among authors: xi zx. Curr Opin Pharmacol. 2021 Feb;56:13-21. doi: 10.1016/j.coph.2020.07.007. Epub 2020 Sep 11. Curr Opin Pharmacol. 2021. PMID: 32927246 Free PMC article. Review.

36

Increased novelty-induced locomotion, sensitivity to amphetamine, and extracellular dopamine in striatum of Zdhhc15-deficient mice.

Mejias R, Rodriguez-Gotor JJ, Niwa M, Krasnova IN, Adamczyk A, Han M, Thomas GM, Xi ZX, Huganir RL, Pletnikov MV, Sawa A, Cadet JL, Wang T. Mejias R, et al. Among authors: xi zx. Transl Psychiatry. 2021 Jan 18;11(1):65. doi: 10.1038/s41398-020-01194-6. Transl Psychiatry. 2021. PMID: 33462194 Free PMC article.

37

New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders.

Newman AH, Ku T, Jordan CJ, Bonifazi A, Xi ZX. Newman AH, et al. Among authors: xi zx. Annu Rev Pharmacol Toxicol. 2021 Jan 6;61:609-628. doi: 10.1146/annurev-pharmtox-030220-124205. Annu Rev Pharmacol Toxicol. 2021. PMID: 33411583 Free PMC article.

38

Progress in opioid reward research: From a canonical two-neuron hypothesis to two neural circuits.

Galaj E, Xi ZX. Galaj E, et al. Among authors: xi zx. Pharmacol Biochem Behav. 2021 Jan;200:173072. doi: 10.1016/j.pbb.2020.173072. Epub 2020 Nov 20. Pharmacol Biochem Behav. 2021. PMID: 33227308 Free PMC article. Review.

39

Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals.

Galaj E, Xi ZX. Galaj E, et al. Among authors: xi zx. Int J Mol Sci. 2020 Dec 24;22(1):134. doi: 10.3390/ijms22010134. Int J Mol Sci. 2020. PMID: 33374481 Free PMC article. Review.

40

Dissecting the Role of GABA Neurons in the VTA versus SNr in Opioid Reward.

Galaj E, Han X, Shen H, Jordan CJ, He Y, Humburg B, Bi GH, Xi ZX. Galaj E, et al. Among authors: xi zx. J Neurosci. 2020 Nov 11;40(46):8853-8869. doi: 10.1523/JNEUROSCI.0988-20.2020. Epub 2020 Oct 12. J Neurosci. 2020. PMID: 33046548 Free PMC article.

41

(±)VK4-40, a novel dopamine D₃ receptor partial agonist, attenuates cocaine reward and relapse in rodents.

Jordan CJ, He Y, Bi GH, You ZB, Cao J, Xi ZX, Newman AH. Jordan CJ, et al. Among authors: xi zx. Br J Pharmacol. 2020 Oct;177(20):4796-4807. doi: 10.1111/bph.15244. Epub 2020 Sep 17. Br J Pharmacol. 2020. PMID: 32851643 Free PMC article.

42

Xie2-64, a novel CB₂ receptor inverse agonist, reduces cocaine abuse-related behaviors in rodents.

Jordan CJ, Feng ZW, Galaj E, Bi GH, Xue Y, Liang Y, McGuire T, Xie XQ, Xi ZX. Jordan CJ, et al. Among authors: xi zx. Neuropharmacology. 2020 Oct 1;176:108241. doi: 10.1016/j.neuropharm.2020.108241. Epub 2020 Jul 24. Neuropharmacology. 2020. PMID: 32712273 Free PMC article.

43

Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctions.

Mereu M, Hiranita T, Jordan CJ, Chun LE, Lopez JP, Coggiano MA, Quarterman JC, Bi GH, Keighron JD, Xi ZX, Newman AH, Katz JL, Tanda G. Mereu M, et al. Among authors: xi zx. Neuropsychopharmacology. 2020 Aug;45(9):1518-1526. doi: 10.1038/s41386-020-0680-5. Epub 2020 Apr 27. Neuropsychopharmacology. 2020. PMID: 32340023 Free PMC article.

44

Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.

Schweppe CA, Burzynski C, Jayanthi S, Ladenheim B, Cadet JL, Gardner EL, Xi ZX, van Praag H, Newman AH, Keck TM. Schweppe CA, et al. Among authors: xi zx. Psychopharmacology (Berl). 2020 Jul;237(7):1989-2005. doi: 10.1007/s00213-020-05513-z. Epub 2020 May 9. Psychopharmacology (Berl). 2020. PMID: 32388619 Free PMC article.

45

Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges.

Galaj E, Newman AH, Xi ZX. Galaj E, et al. Among authors: xi zx. Neurosci Biobehav Rev. 2020 Jul;114:38-52. doi: 10.1016/j.neubiorev.2020.04.024. Epub 2020 May 3. Neurosci Biobehav Rev. 2020. PMID: 32376243 Free PMC article. Review.

46

Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.

Bi GH, Galaj E, He Y, Xi ZX. Bi GH, et al. Among authors: xi zx. Addict Biol. 2020 Jul;25(4):e12783. doi: 10.1111/adb.12783. Epub 2019 Jun 19. Addict Biol. 2020. PMID: 31215752 Free PMC article.

47

β-Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents.

He Y, Galaj E, Bi GH, Wang XF, Gardner E, Xi ZX. He Y, et al. Among authors: xi zx. Br J Pharmacol. 2020 May;177(9):2058-2072. doi: 10.1111/bph.14969. Epub 2020 Feb 15. Br J Pharmacol. 2020. PMID: 31883107 Free PMC article.

48

Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT_1A and TRPV1 receptor mechanisms.

Galaj E, Bi GH, Yang HJ, Xi ZX. Galaj E, et al. Among authors: xi zx. Neuropharmacology. 2020 May 1;167:107740. doi: 10.1016/j.neuropharm.2019.107740. Epub 2019 Aug 19. Neuropharmacology. 2020. PMID: 31437433 Free PMC article.

49

Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB₁ /CB₂ versus GPR55 receptors.

Wang XF, Galaj E, Bi GH, Zhang C, He Y, Zhan J, Bauman MH, Gardner EL, Xi ZX. Wang XF, et al. Among authors: xi zx. Br J Pharmacol. 2020 Apr;177(8):1865-1880. doi: 10.1111/bph.14958. Epub 2020 Feb 11. Br J Pharmacol. 2020. PMID: 31877572 Free PMC article.

50

Newly Developed Dopamine D₃ Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats.

Jordan CJ, Humburg BA, Thorndike EB, Shaik AB, Xi ZX, Baumann MH, Newman AH, Schindler CW. Jordan CJ, et al. Among authors: xi zx. J Pharmacol Exp Ther. 2019 Dec;371(3):602-614. doi: 10.1124/jpet.119.259390. Epub 2019 Sep 27. J Pharmacol Exp Ther. 2019. PMID: 31562201 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

165 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Results by year